Hologic is down approximately 20% from recent highs and continues to grow organically and via a series of 'bolt-on' ...

The U.S. Food and Drug Administration has sent a warning letter to Marlborough, Mass.-based medical technology company ...

With a market cap of $15.9 billion, Marlborough, Massachusetts-based Hologic, Inc. (HOLX) specializes in developing, ...

Hologic announced today that it has completed its previously announced $350 million acquisition of Gynesonics.

Hologic Inc. has received a warning letter from the Food and Drug Administration regarding its BioZorb product line, even ...

FDA issues warning to Hologic, citing manufacturing and safety violations for BioZorb devices. Patient safety risks and reporting failures highlighted ...

Hologic (HOLX) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term. Over the ...

In the closing of the recent trading day, Hologic (HOLX) stood at $70.20, denoting a -0.13% change from the preceding trading day.

Leerink Partners analyst Puneet Souda has maintained their bullish stance on HOLX stock, giving a Buy rating on January 13.Stay Ahead of the ...

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Hologic (HOLX – Research Report) and Arcutis ...

MARLBOROUGH, Mass., January 07, 2025 -- ( BUSINESS WIRE )--Hologic, Inc. (Nasdaq: HOLX) announced today that the Company will ...

Nordea Investment Management AB boosted its position in shares of Hologic, Inc. (NASDAQ:HOLX – Free Report) by 32.7% in the ...